Ipratropium, salmeterol show therapeutic potential in multiple sclerosis
Use of both ipratropium and salmeterol is associated with reduced likelihood of being diagnosed with multiple sclerosis, according to a study, suggesting that the drugs may help prevent or stop the development of the disease in its early stages.
Ipratropium, salmeterol show therapeutic potential in multiple sclerosis
25 Sep 2019